|
|
|
Personalized Medicine: A Call for Action is the third in a series of annual conferences dedicated to explore the opportunities to make Personalized Medicine a reality. It will be a one and a half day conference reflecting a distinctive collaboration between the Harvard Medical School-Partners HealthCare Center for Genetics and Genomics and Harvard Business School. The alliance of these two renowned academic institutions presents an exceptional opportunity to address the integration of medicine and business in accelerating the adoption of Personalized Medicine by bringing together stakeholders, including leaders from pharmaceutical and diagnostics companies, medicine, academia, healthcare providers and payers, regulatory agencies, venture capitalists and the business community.
Participants will engage in a multitude of issues surrounding the obstacles to the adoption of personalized medicine and showcasing evidence that will stimulate these stakeholders to act and overcome these barriers, which will change the practice of medicine by continuing to incorporate genetics and genomics into clinical practice to achieve better outcomes for patients in a cost effective manner. The conference will explore from multiple perspectives how the Personalized Medicine revolution has been put into practice and what is required on the part of physicians, patients, payers, provider organizations, pharmaceutical innovators and the business community to ensure its future success. This conference will be unique in its depth and breadth, in its roster of prestigious speakers from government, academic and industry and in its ability to define and address the issues that confront us as Personalized Medicine becomes even more of a reality.
|
|
|
|
|
Thursday, November 29
|
| TIME |
ACTIVITY |
| 7:30-8:30 |
Breakfast & Registration
|
| 8:15 |
Welcome
Raju Kucherlapati, Ph.D., Scientific Director, Harvard Medical School-Partners HealthCare
Center for Genetics and Genomics, Paul C. Cabot Professor of Genetics, Professor of Medicine,
Harvard Medical School, Boston, MA
|
| 8:25 |
Keynote Speaker
M. Kathleen Behrens, Ph.D., General Partner, Consultant, RS Investments, Member, President’s
Council of Advisors on Science and Technology (PCAST), Ross, CA
PRESENTATION
Introduction by: Mark J. Levin, Partner, Third Rock Ventures, LLC, Boston, MA
|
| 9:10 |
Keynote Speaker
The Personalized Health Care Challenge
Michael O. Leavitt, Secretary of Health and Human Services, U.S. Department of Health and
Human Services, Washington, DC
Introduction by: James J. Mongan, M.D., Chief Executive Officer, Partners HealthCare System,
Inc., Boston, MA
|
| 10:00 |
Break & Snack
|
| 10:45-12:15 |
Session I: Perspectives from Pharmaceutical and Diagnostics Companies
Moderator: Richard G. Hamermesh, D.B.A., MBA Class of 1961 Professor of Management
Practice, Faculty Chair, HBS Healthcare Initiative, Harvard Business School, Cambridge, MA
|
Seven-minute talks
by each speaker |
Thomas J. Miller, Member, Executive Management Board, Siemens Medical Solutions,
Erlangen, Germany
Garry Neil, M.D., President, Johnson & Johnson Pharmaceutical Research & Development,
Raritan, NJ
Samuel Broder, M.D., Chief Medical Officer, Celera, Rockville, MD
Peer M. Schatz, Chief Executive Officer, Qiagen, Germany
PRESENTATION
Panel Discussion - one hour
|
| 12:15 |
Personalized Medicine Coalition's Third Annual Award for Leadership in Personalized Medicine
Presentation
Award Recipient: Ralph Snyderman, M.D., Emeritus Chancellor for Health Affairs and President
and CEO, Duke University Health System, Chairman and CEO, Proventys, Inc., Durham, NC
Introduction by: Edward Abrahams, Ph.D., Executive Director, Personalized Medicine Coalition,
Washington, DC
Presentation by: Mara G. Aspinall, President, Genzyme Genetics, Genzyme Corporation,
Westborough, MA
Plated Lunch
|
| 2:15 |
Keynote Speaker
Markets of One: The Pharmaceutical Industry and the Pursuit of Personalized Medicine
John C. Lechleiter, Ph.D., President and Chief Operating Officer, Eli Lilly and Company,
Indianapolis, IN
PRESENTATION
Introduction by: Deborah Dunsire, M.D., President and CEO, Millennium Pharmaceuticals, Inc.,
Cambridge, MA
|
| 3:00 |
Break & Snack
|
| 3:30 - 5:00 |
Session II: Personalized Medicine: Clinical and Regulatory Issues
Moderator: Christine Seidman, M.D. Investigator, Howard Hughes Medical Institute, Thomas
W. Smith Professor of Medicine and Genetics, Harvard Medical School, Director, Cardiovascular
Genetics Center, Brigham and Women’s Hospital, Boston, MA
|
Seven-minute talks
by each speaker |
Nadine Cohen, Ph.D., Head of Pharmacogenomics and Senior Research Fellow, Johnson &
Johnson Pharmaceutical Research & Development East Coast and Europe, Raritan, NJ
PRESENTATION
Mason W. Freeman, M.D., Chief, Lipid Metabolism Unit, Massachusetts General Hospital,
Harvard Medical School, Boston, MA
Felix W. Frueh, Ph.D., Associate Director, Genomics, Office of Clinical Pharmacology,
CDER/FDA, Silver Spring, MD
Hakan Sakul, Ph.D., Senior Director and Global Head of Diagnostics, Translational and
Molecular Medicine Group, Worldwide Development, Pfizer Global R&D
Panel Discussion – one hour
|
| 5:00 |
Reception
|
| 6:30 |
VIP Dinner at Great Bay Restaurant, Hotel Commonwealth, Boston for Organizing Committee, Speakers,
Sponsors and other VIP guests
|
|
| |
|
Friday, November 30
|
| TIME |
ACTIVITY |
| 7:30-8:30 |
Breakfast
|
| 8:30 |
Keynote Speaker
Richard M.J. Bohmer, M.D., MBA Class of 1973 Senior Lecturer of Business Administration,
Harvard Business School, Cambridge, MA
Introduction by: Norman C. Selby, Senior Managing Director, Perseus, L.L.C., New York, NY (need
to confirm)
|
| 9:15-9:45 |
Keynote Speaker
Personalized Healthcare: A Way Forward
Wayne A. Rosenkrans, Jr., Ph.D., President & Chairman, Personalized Medicine Coalition,
External Relations Director – Evidence-based Medicine and Personalized Healthcare,
AstraZeneca Pharmaceuticals, Wilmington, DE
PRESENTATION
Introduction by: Marcia A. Kean, Chief Executive Officer, Feinstein Kean Healthcare, Cambridge,
MA
|
| 9:45-11:00 |
Session III: Who Will Pay for Personalized Medicine?
Moderator: Edward Abrahams, Ph.D., Executive Director, Personalized Medicine Coalition,
Washington DC
|
Seven-minute talks
by each speaker |
Joanne C. Armstrong, M.D., M.P.H., Senior Medical Director for Women's Health and Clinical
Lead for Genomics, Aetna, Inc., Sugarland, TX
Anthony Miller, Managing Director, Lemhi Ventures, Excelsior, MN
Samuel R. Nussbaum, M.D., Executive Vice President and Chief Medical Officer, Wellpoint, Inc.,
Indianapolis, IN
Dora L. Hughes, M.D., M.P.H., Health Policy Advisor, Senator Barack Obama, Washington, DC
Panel Discussion - one hour
|
| 11:00 |
Break & Snack
|
| 11:30-12:45 |
Session IV: What are the Public Policy and IT Issues that will Drive Personalized Medicine?
Moderator: Gregory Downing, D.O., Ph.D., Program Director, Personalized Health Care, U.S.
Department of Health and Human Services, Bethesda, MD
|
Seven-minute talks
by each speaker |
John P. Glaser, Ph.D., Vice President and Chief Information Officer, Partners HealthCare
System, Inc., Boston, MA
Lawrence J. Lesko, Ph.D., FCP, Director, Office of Clinical Pharmacology, Center for Drug
Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD
Jeffrey D. Miller, Vice President, WW Health and Life Sciences, WW Public Sector,
Hewlett-Packard Company, Houston, TX
Sharon F. Terry, M.A., President and CEO, Genetic Alliance, Washington, DC
Panel Discussion - one hour
|
| 12:45 |
Closing
Raju Kucherlapati, Ph.D., Scientific Director, Harvard Medical School-Partners HealthCare
Center for Genetics and Genomics, Paul C. Cabot Professor of Genetics, Professor of Medicine,
Harvard Medical School, Boston, MA
|
| 1:00 |
Bag Lunch
|
|
Back to Top |
Raju Kucherlapati, Ph.D., Chair
Scientific Director
Harvard-Partners Center for Genetics and Genomics
Paul C. Cabot Professor of Genetics
Professor of Medicine
Harvard Medical School
Edward Abrahams, Ph.D.
Executive Director
Personalized Medicine Coalition
Joanne C. Armstrong, M.D.
Senior Medical Director for Women's Health and Clinical Lead for Genomics
Aetna, Inc.
Mara G. Aspinall
President, Genzyme Genetics
Genzyme Corporation
|
M. Kathleen Behrens Wilsey, Ph.D.
Managing Director
Robertson Stephens & Company
Nadine Cohen, Ph.D.
Head of Pharmacogenomics and
Senior Research Fellow
Johnson & Johnson Pharmaceutical Research and Development, East Coast and Europe
Peter Dworkin
Vice President
Investor Relations and Corporate Communications
Applera Corporation
Richard G. Hamermesh, D.B.A.
MBA Class of 1961 Professor of Management Practice
Harvard Business School
|
Regina E. Herzlinger, D.B.A.
Nancy R. McPherson Professor of Business Administration
Harvard Business School
Marcia A. Kean
Chief Executive Officer
Feinstein Kean Healthcare
Jeffrey D. Miller
Vice President, Worldwide Health and Life Sciences Industries
Hewlett-Packard Company
Daniel K. Podolsky, M.D.
Chief Academic Officer
Partners HealthCare System, Inc.
Mallinckrodt Professor of Medicine
Harvard Medical School
Eiry W. Roberts, M.D.
Vice President, Project/Program Medical
Eli Lilly and Company
|
Hakan Sakul, Ph.D.
Senior Director and Global Head of Diagnostics
Translational and Molecular Medicine Group
Worldwide Development
Rick Schlesinger
Director
McKinsey & Company
Christine Seidman, M.D.
Investigator, Howard Hughes Medical Institute
Thomas W. Smith Professor of Medicine and Genetics
Harvard Medical School
Director
Cardiovascular Genetics Center
Brigham and Women's Hospital
|
|
Back to Top |
"Personalized Medicine: The Future Is (Almost) Now"
Parsons, Heidi. PharmaManufacturing.com.
"Dr. Ralph Snyderman, Chancellor Emeritus, Duke University, and Founder and Chairman..."
Mackenzie, Christine. Reuters. 29 November 2007.
"HHS secretary promotes personalized medicine at Harvard forum"
Cooney, Elizabeth. Boston Globe White Coat Notes. 29 November 2007.
"PCAST Personalized Medicine Draft Report Slated for Spring 2008"
Ray, Turna. GenomeWeb Daily News. 30 November 2007.
"Meeting Offers Vision of Future U.S. Personalized Healthcare System"
Allison, Malorye. Xconomy. 3 December 2007.
"Personalized Medicine - Myth, Pipe Dream or Realizable Promise?"
De, Andy. Andy De Blogspot. 4 December 2007.
"Will HPCGG's New Algorithm Spur Market Adoption of PGx-Based Warfarin Dosing?"
"Lilly Official Proclaims Company 'On Board' With Personalized Medicine."
"PCAST Plans Draft Personalized Medicine Report for Spring; Reimbursement Key Issue."
Ray, Turna. Pharmacogenomics Reporter. 5 December 2007.
Subscription required for full content.
"J&J Official Discusses How PGx Helps Company Set 'Realistic Expectations'"
"Dx Shops' Flexibility Will Encourage Co-Development Alliances, Qiagen CEO"
"HHS Chief Leavitt May Leave in '09; Vows To Keep Personalized Medicine enter Stage"
Ray, Turna. Pharmacogenomics Reporter. 12 December 2007.
Subscription required for full content.
"Insurers Say More Evidence Needed for Significant Resource Push Behind PGx"
Ray, Turna. Pharmacogenomics Reporter. 19 December 2007.
Subscription required for full content.
"Musings on up-close-and-personal medicine"
Parsons, Heidi. PharmaManufacturing.com. 31 December 2007.
|
|
Back to Top |
|
SPONSORS
|
PLATINUM
|
GOLD
|
SILVER
|
BRONZE
|
OTHER
|
Back to Top |
|
This year's Personalized Medicine Conference will take place November 13-14, 2008 at the Joseph B. Martin Conference Center at Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA. Visit our website again in the spring for more details. We hope you can join us!
|
|
Back to Top |
|
For additional information, please contact Janice Larson at jalarson@partners.org or 617-525-4489
|
|
Please send your comments or questions regarding this website to
web master.
|
